Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

被引:2
|
作者
Decary, Simon [1 ]
de Wit, Maarten [2 ]
Naye, Florian [1 ]
Barton, Jennifer L. [3 ]
Fraenkel, Liana [4 ]
Li, Linda C. [5 ,6 ]
Brooks, Peter [7 ,8 ]
Stacey, Dawn [9 ,10 ]
Maxwell, Lara J. [11 ,12 ]
Campbell, Willemina [13 ]
Hofstetter, Cathie
Voshaar, Marieke [14 ,15 ,16 ]
Meara, Alexa [17 ]
Christensen, Robin [18 ,19 ]
Boonen, Annelies [20 ,21 ]
Suarez-Almazor, Maria E. [22 ]
Meade, Tanya [23 ]
March, Lyn [24 ]
Jull, Janet Elizabeth [25 ]
Alten, Rieke [26 ]
Morgan, Esi M. [27 ]
Hazlewood, Glen Stewart [28 ]
Barber, Claire E. H. [29 ]
Guillemin, Francis [30 ]
El-Miedany, Yasser [31 ,32 ]
Mittoo, Shikha [33 ]
Robertson, Tiffany Westrich [34 ]
Bartlett, Susan J. [35 ,36 ,37 ]
Singh, Jasvinder A. [38 ]
Mannion, Melissa [39 ]
Nasef, Samah Ismail [40 ]
Boel, Anne [41 ,42 ]
Adebajo, Adewale [43 ]
Arnaud, Laurent [44 ]
Gill, Tiffany K. [45 ]
Moholt, Ellen [46 ]
Burt, Jennifer [47 ]
Jayatilleke, Arundathi [48 ]
Hmamouchi, Ihsane [49 ]
Berthelsen, Dorthe B. [50 ,51 ,52 ]
Blanco, Francisco J. [53 ]
Mather, Kate [54 ]
Maharaj, Ajesh [55 ]
Sharma, Saurab [56 ,57 ]
Caso, Francesco [58 ]
Beaton, Dorcas [59 ]
Shea, Beverly [60 ,61 ,62 ]
Fong, Christopher [63 ]
Fernandez, Anthony P. [64 ,65 ]
Mackie, Sarah [66 ]
机构
[1] Univ Sherbrooke, Sch Rehabil,Fac Med & Hlth Sci, Res Ctr,CHUS, CIUSSS EstrieCHUS, Sherbrooke, PQ, Canada
[2] Patient Res Partner, Amsterdam, Netherlands
[3] Oregon Hlth & Sci Univ, VA Portland Hlth Care Syst, Portland, OR USA
[4] Yale Univ, Dept Internal Med, New Haven, CT USA
[5] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada
[6] Arthrit Res Canada, Vancouver, BC, Canada
[7] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Australia
[8] Northern Hlth, Melbourne, Australia
[9] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada
[10] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[11] Univ Ottawa, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada
[12] Univ Ottawa, Fac Med, Ottawa, ON, Canada
[13] Toronto Western Hosp, Univ Hlth Network, Patient Res Partner, Toronto, ON, Canada
[14] Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands
[15] Sint Maartenskliniek, Dept Res Innovat, Nijmegen, Netherlands
[16] Radboud Univ Nijmegen, Dept Pharm, Med Ctr, Nijmegen, Netherlands
[17] Ohio State Univ, Div Rheumatol, Columbus, OH USA
[18] Bispebjerg & Frederiksberg Hosp, Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark
[19] Odense Univ Hosp, Dept Rheumatol, Odense, Denmark
[20] Maastricht Univ, Div Rheumatol, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[21] Maastricht Univ, Caphri Res Inst, Maastricht, Netherlands
[22] Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX USA
[23] Western Sydney Univ, Sydney, NSW, Australia
[24] Royal North Shore Hosp Univ Sydney, Dept Rheumatol, Sydney, Australia
[25] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada
[26] Univ Med Berlin, Dept Internal Med 2, Schlosspark Klin,Rheumatol Res Ctr, Clin Immunol Osteol Phys Therapy & Sports Med, Berlin, Germany
[27] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Div Rheumatol, Seattle, WA USA
[28] Univ Calgary, Dept Med, Calgary, AB, Canada
[29] Univ Calgary, Cumming Sch Med, Dept Med, Dept Community Hlth Sci, Calgary, AB, Canada
[30] Univ Lorraine, INSPIIRE, INSERM, Nancy, France
[31] Canterbury Kings Coll London, Canterbury, Kent, England
[32] Kings Coll London, London, England
[33] Vanshavardhana Canada Integrated Hlth, Toronto, ON, Canada
[34] Int Fdn Autoimmune & Autoinflammatory Arthrit Ai, New York, NY USA
[35] McGill Univ, Div Clin Epidemiol, Rheumatol & Resp Epidemiol & Clin Trials Unit, Montreal, PQ, Canada
[36] McGill Univ Hlth Ctr, Res Inst, Montreal, PQ, Canada
[37] Johns Hopkins Med, Div Rheumatol, Montreal, PQ, Canada
[38] Univ Alabama Birmingham, Birmingham, AL USA
[39] Univ Alabama Birmingham, Div Pediat Rheumatol, Dept Pediat, Birmingham, AL USA
[40] Suez Canal Univ, Dept Rheumatol & Rehabil, Fac Med, Ismailia, Egypt
[41] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands
[42] UCB Pharma B V Netherlands, Leiden, Netherlands
[43] Univ Sheffield, Fac Med Dent & Hlth, Sheffield, S Yorkshire, England
[44] Univ Hosp Strasbourg, Dept Rheumatol, CRMR RESO, Strasbourg, France
[45] Univ Adelaide, Adelaide Med Sch, Fac Hlth & Med Sci, Adelaide, SA, Australia
[46] Diakonhjemmet Hosp, Ctr treatment Rheumat & Musculoskeletal Dis REMED, Oslo, Norway
[47] St Clares Mercy Hosp, Newfoundland & Labrador Hlth Serv, St John, NF, Canada
[48] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA USA
[49] Int Univ Rabat UIR, Hlth Sci Res Ctr CReSS, Fac Med, Rabat, Morocco
[50] Bispebjerg & Frederiksberg Hosp, Parker Inst, Sect Biostat & Evidence Based Res, Copenhagen, Denmark
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
OMERACT; Rheumatology; Shared decision making; Core domain set; Consensus-building; Survey;
D O I
10.1016/j.semarthrit.2024.152381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To gain consensus on the definitions and descriptions of the domains of the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials evaluating shared decision making (SDM) interventions. Methods: Following the OMERACT Handbook methods, our Working Group (WG), comprised of 90 members, including 17 patient research partners (PRPs) and 73 clinicians and researchers, had six virtual meetings in addition to email exchanges to develop draft definitions and descriptions. The WG then conducted an international survey of its members to gain consensus on the definitions and descriptions. Finally, the WG members had virtual meetings and e-mail exchanges to review survey results and finalize names, definitions and descriptions of the domains. Results: WG members contributed to developing the definitions. Fifty-two members representing four continents and 13 countries completed the survey, including 15 PRPs, 33 clinicians and 37 researchers. PRPs and clinicians/ researchers agreed with all definitions and descriptions with agreements ranging from 87% to 100%. Respondents suggested wording changes to the names, definitions and descriptions to better reflect the domains. Discussions led to further simplification and clarification to address common questions/concerns about the domains. Conclusion: Our WG reached consensus on the definitions and descriptions of the domains of the core domain set for rheumatology trials of SDM interventions. This step is crucial to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set. Clinical significance: The current study provides consensus-based definitions and descriptions for the domains of the OMERACT core domain set for shared decision making interventions from patients/caregivers, clinicians and researchers. This is a crucial step to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set for trials of SDM interventions.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Scoping Literature Review to Identify Candidate Domains for the SLE OMERACT Core Outcome Set
    Nielsen, Wils
    Kharouf, Fadi
    Munoz-Grajales, Carolina
    Thayaparan, Aarabi
    Anderson, Melanie
    Simon, Lee
    Desai, Maya
    Parodis, Ioannis
    Kim, Alfred
    Enman, Yvonne
    Bingham, Kathleen
    Bonilla, Dennisse
    Thumboo, Julian
    Mosca, Marta
    Aringer, Martin
    Morand, Eric
    Bruce, Ian
    Strand, Vibeke
    Touma, Zahi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1325 - 1328
  • [22] OMERACT 7 - 7th international consensus conference on outcome measures in rheumatology clinical trials
    Strand, CV
    Simon, LS
    Tugwell, R
    Brooks, P
    Boers, M
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (10) : 2014 - 2015
  • [23] OMERACT 9-9th International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials
    Tugwell, Peter
    Boers, Maarten
    Strand, Vibeke
    Simon, Lee S.
    Brooks, Peter
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (08) : 1767 - 1768
  • [24] OMERACT 8 - 8th International consensus conference on outcome measures in rheumatology clinical trials
    Boers, Maarten
    Strand, Vibeke
    Simon, Lee S.
    Tugwell, Peter
    Brooks, Peter
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (03) : 599 - 599
  • [25] A FRAMEWORK AND PROCESS TO DEVELOP CORE OUTCOME MEASUREMENT SETS FOR CLINICAL TRIALS IN RHEUMATOLOGY: OMERACT FILTER 2.0
    Boers, M.
    Kirwan, J. R.
    Wells, G.
    Beaton, D.
    Gossec, L.
    d'Agostino, M. -A.
    Conaghan, P. G.
    Bingham, C. O.
    Brooks, P. M.
    Landewe, R. B. M.
    March, L.
    Simon, L. S.
    Singh, J. A.
    Strand, V.
    Tugwell, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 550 - 551
  • [26] Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group
    Singh, Jasvinder A.
    Dohm, Michael
    Choong, Peter F.
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [27] Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group
    Jasvinder A. Singh
    Michael Dohm
    Peter F. Choong
    BMC Musculoskeletal Disorders, 18
  • [28] Designing Clinical Trials for Shared Decision-Making Interventions in Nephrology
    Law, Makenna
    Weiner, Daniel E.
    Ladin, Keren
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 82 (02) : 176 - 178
  • [29] Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol
    Chapman, Lara S.
    Redmond, Anthony C.
    Flurey, Caroline A.
    Richards, Pamela
    Smith, Toby O.
    Arnold, John B.
    Beaton, Dorcas
    Conaghan, Philip G.
    Golightly, Yvonne M.
    Hannan, Marian T.
    Hofstetter, Catherine
    Maxwell, Lara J.
    Menz, Hylton B.
    Shea, Beverley
    Tugwell, Peter
    Helliwell, Philip
    Siddle, Heidi J.
    TRIALS, 2023, 24 (01)
  • [30] The OMERACT Core Set of Outcome Measures for Use in Clinical Trials of ANCA-associated Vasculitis
    Merkel, Peter A.
    Aydin, Sibel Z.
    Boers, Maarten
    Direskeneli, Haner
    Herlyn, Karen
    Seo, Philip
    Suppiah, Ravi
    Tomasson, Gunnar
    Luqmani, Raashid A.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (07) : 1480 - 1486